Transplant Medicine
Transplant Medicine is a key segment within the Healthcare sector, comprising 625+ companies actively operating in this space.
This segment represents businesses focused on specific activities and services within Healthcare. Companies in this segment share common characteristics, market positioning, and often face similar challenges and opportunities.
Browse the comprehensive directory of Transplant Medicine companies to access detailed profiles, financial information, funding rounds, investor details, and other critical business intelligence for research, due diligence, and market analysis.
Discover leading companies in this segment, ranked by company performance and market presence.
Medical solutions for transplant patients are developed and provided.
Developer of organ transplantation technology
Warm storage and transport systems for harvested organs are provided.
Human tissue-based products are developed for vascular disease applications.
Next-generation medicines for CNS and immunological disorders are developed.
Breakthrough therapies are developed for blood diseases and infections.
Personalized skin tissue therapy is developed by CUTISS for surgeries.
Game currency trading services are provided by Magenta Piman.
T regulatory cell therapies are developed for immunological diseases.
Therapeutics for transplantation in autoimmune and neurodegenerative diseases are developed.
Stem cell therapies are developed for treating multiple diseases.
Multi-organ support systems for liver, lung, and kidney are provided.
Plasma-derived therapies are developed for hemophilia and immune deficiencies.
Organ preservation and transport systems are developed for transplants.
In-vitro diagnostics are developed for oncology, transplants, and neurodegeneration.
Cold storage solutions for organ transplant preservation are provided.
Immune markers are utilized by Oxford Immunotec for disease diagnostics.
Immunotherapies for oncology and autoimmune diseases are developed.
Developer of diagnostic solutions for organ transplants
Genomic medicines for liver diseases are developed using gene therapies.
Explore Companies in Transplant Medicine
Access detailed company profiles, financial data, funding information, and more for all companies in this segment.
View All Companies